U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT06880848) titled 'Sonidegib in Adult Patients with Locally Advanced Basal Cell Carcinoma (laBCC) in China' on March 12.
Brief Summary: This is a Phase IV, single arm, multicenter study designed to evaluate the efficacy and safety profile of Sonidegib in chinese participants with locally advanced basal cell carcinoma (laBCC) who are not amenable to radiation therapy, curative surgery or other local therapies.
Study Start Date: June 21, 2023
Study Type: INTERVENTIONAL
Condition:
Carcinoma, Basal Cell (BCC)
Intervention:
DRUG: Sonidegib Phosphate Capsules
Sonidegib should be taken 1 hour before or 2 hours after a breakfast
Recruitment Status: A...